Genitourinary Oncology Update 2021

Presented April 28, 2021 as part of the UNC Lineberger Cancer Network’s Research to Practice lecture series.

Presenter

Matthew I. Milowsky, MD
The George Gabriel and Frances Gable Villere Distinguished Professor of Bladder and Genitourinary Cancer Research
Section Chief, Genitourinary Oncology
Co-Director, Urologic Oncology Program
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Genitourinary Oncology Update 2021

Genitourinary malignances will account for approximately 20% of newly diagnosed cancers in 2021. Recent research advances in prostate, bladder, and kidney cancers utilizing new biomarkers and imaging tools, radiolabeled therapy, targeted therapy, immunotherapy and antibody-drug conjugates have led to new management approaches associated with significant improvements in patient outcomes.

Learning Objective

• Describe new PSMA-directed approaches in the imaging and management of patients with prostate cancer.
• Review recent advances in systemic therapy for patients with muscle-invasive and metastatic bladder cancer.
• Discuss the use of immunotherapy and targeted therapy approaches in the management of advanced kidney cancer.

Credits Offered

• 1.0 ANCC (NCPD/CNE) hours of study.
• 1 ASRT Category A CE Credit
• 1.0 AMA PRA Category 1 Credit™
• 1.0 ACPE contact hour
• General Participation

Requirements

To receive credit for this course, you must:

1. Attend at least 50 minutes minutes of the session.
2. Obtain the attendance verification password from your site coordinator or via the attendee follow-up email from the UNCLCN Site Coordinator.
3. Complete the course evaluation.
4. Select credit type.

Estimated course completion time: 10 minutes

Disclosures

This activity has been planned and implemented under the sole supervision of the course directors, in association with the UNC Office of Continuing Professional Development (UNC CPD). William A Wood, MD, MPH, and CPD staff have no relevant financial relationships with commercial interests as defined by the ACCME.

The speaker, Matthew I. Milowsky, MD, has no relevant financial relationships with commercial interests as defined by the ACCME.

Accreditation

The University of North Carolina at Chapel Hill is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Approved by the American Society of Radiologic Technologists (ASRT).

Approved by the UNC Eshelman School of Pharmacy for ACPE.

The UNC School of Medicine of The University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  The School of Medicine of The University of North Carolina at Chapel Hill designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.